LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Social Networks
• Health & Fitness
• Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

bone, article, raloxifene, osteoporosis, postmenopausal, women, density, treatment, group, bmd, serum, rlx, privacy, cookies, content, low, study, access, information, publish, research, search, placebo, significantly, france, lilly, data, log, journal, meunier, vignot, garnero, month, lumbar, spine, groups, mgday, increased, compared, decreased, discover, springer, optional, personal, parties, policy, find, track, international, cite,

Topics {✒️}

60 mg/day raloxifene-hcl 150 mg/day raloxifene-hcl double-masked study assessed raloxifene/cholecalciferol combination therapy month download article/chapter low bone density decreased bone turnover privacy choices/manage cookies bone turnover markers ldl-cholesterol levels full article pdf /day vitamin d3 serum lipid profiles serum lipid profile raloxifene-treated patients de pathologie osseuse lilly corporate center european economic area scope submit manuscript hôpital edouard herriot investigation des osteoporoses conditions privacy policy serum lipids healthy postmenopausal women accepting optional cookies minimal adverse events main content log rlx-treated groups journal finder publish bone metabolism raloxifene treatment check access instant access significantly decreased rlx 150 group lumbar spine patient discontinuation related subjects article log liu-leage privacy policy personal data serum osteocalcin treatment groups effective treatment books a significantly increased placebo group article cite information

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Treatment of Postmenopausal Women with Osteoporosis or Low Bone Density with Raloxifene
         description: Raloxifene, a selective estrogen receptor modulator (SERM), has been shown to improved bone mineral density (BMD) and serum lipid profiles in healthy postmenopausal women. The objective of this study was to examine the effects of raloxifene on BMD, biochemical markers of bone metabolism and serum lipids in postmenopausal women with low bone density or osteoporosis. This Phase II, multicenter, 24-month, double-masked study assessed the efficacy and safety of raloxifene in 129 postmenopausal women (mean age ± SD: 60.2 ± 6.7 years) with osteoporosis or low bone density (baseline mean lumbar spine BMD T-score: −2.8). Women were randomly assigned to one of three treatment groups: placebo, 60 mg/day raloxifene-HCl (RLX 60) or 150 mg/day raloxifene-HCl (RLX 150) and concomitantly received 1000 mg/day calcium and 300 U/day vitamin D3. At 24 months, BMD was significantly increased in the lumbar spine (+3.2%), femoral neck (+2.1%), trochanter (+2.7%) and total hip (+1.6%) in the RLX 60 group compared with the placebo group (p<0.05). The RLX 150 group had increases in BMD similar to those observed with RLX 60. A greater percentage of raloxifene-treated patients, compared with those receiving placebo, had increased BMD (p<0.05). Serum bone-specific alkaline phosphatase activity, serum osteocalcin, and urinary type I collagen:creatinine ratio were significantly decreased in the RLX-treated groups, compared with the placebo group (p<0.01). RLX 60 treatment significantly decreased serum levels of triglycerides, and total- and LDL-cholesterol levels (p<0.01). The rates of patient discontinuation and adverse events were not significantly different among groups. In this study, raloxifene increased bone density, decreased bone turnover, and improved the serum lipid profile with minimal adverse events, and may be a safe and effective treatment for postmenopausal women with osteoporosis or low bone density.
         datePublished:
         dateModified:
         pageStart:330
         pageEnd:336
         sameAs:https://doi.org/10.1007/s001980050236
         keywords:
            Key words:Bone density – Lipids – Menopause – Osteoporosis – Raloxifene
            Orthopedics
            Endocrinology
            Rheumatology
         image:
         isPartOf:
            name:Osteoporosis International
            issn:
               1433-2965
               0937-941X
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag London Limited
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:P. J. Meunier
               affiliation:
                     name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
                     address:
                        name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. Vignot
               affiliation:
                     name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
                     address:
                        name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
                        type:PostalAddress
                     type:Organization
               type:Person
               name:P. Garnero
               affiliation:
                     name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
                     address:
                        name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. Confavreux
               affiliation:
                     name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
                     address:
                        name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. Paris
               affiliation:
                     name:Centre Lyonnais d’Investigation des Osteoporoses (CLIOS), Lyon, France
                     address:
                        name:Centre Lyonnais d’Investigation des Osteoporoses (CLIOS), Lyon, France, , FR
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Liu-Leage
               affiliation:
                     name:Lilly France (Saint Cloud), Saint Cloud, France;
                     address:
                        name:Lilly France (Saint Cloud), Saint Cloud, France;, , FR
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Sarkar
               affiliation:
                     name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
                     address:
                        name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T. Liu
               affiliation:
                     name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
                     address:
                        name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. Wong
               affiliation:
                     name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
                     address:
                        name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. W. Draper
               affiliation:
                     name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
                     address:
                        name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Treatment of Postmenopausal Women with Osteoporosis or Low Bone Density with Raloxifene
      description: Raloxifene, a selective estrogen receptor modulator (SERM), has been shown to improved bone mineral density (BMD) and serum lipid profiles in healthy postmenopausal women. The objective of this study was to examine the effects of raloxifene on BMD, biochemical markers of bone metabolism and serum lipids in postmenopausal women with low bone density or osteoporosis. This Phase II, multicenter, 24-month, double-masked study assessed the efficacy and safety of raloxifene in 129 postmenopausal women (mean age ± SD: 60.2 ± 6.7 years) with osteoporosis or low bone density (baseline mean lumbar spine BMD T-score: −2.8). Women were randomly assigned to one of three treatment groups: placebo, 60 mg/day raloxifene-HCl (RLX 60) or 150 mg/day raloxifene-HCl (RLX 150) and concomitantly received 1000 mg/day calcium and 300 U/day vitamin D3. At 24 months, BMD was significantly increased in the lumbar spine (+3.2%), femoral neck (+2.1%), trochanter (+2.7%) and total hip (+1.6%) in the RLX 60 group compared with the placebo group (p<0.05). The RLX 150 group had increases in BMD similar to those observed with RLX 60. A greater percentage of raloxifene-treated patients, compared with those receiving placebo, had increased BMD (p<0.05). Serum bone-specific alkaline phosphatase activity, serum osteocalcin, and urinary type I collagen:creatinine ratio were significantly decreased in the RLX-treated groups, compared with the placebo group (p<0.01). RLX 60 treatment significantly decreased serum levels of triglycerides, and total- and LDL-cholesterol levels (p<0.01). The rates of patient discontinuation and adverse events were not significantly different among groups. In this study, raloxifene increased bone density, decreased bone turnover, and improved the serum lipid profile with minimal adverse events, and may be a safe and effective treatment for postmenopausal women with osteoporosis or low bone density.
      datePublished:
      dateModified:
      pageStart:330
      pageEnd:336
      sameAs:https://doi.org/10.1007/s001980050236
      keywords:
         Key words:Bone density – Lipids – Menopause – Osteoporosis – Raloxifene
         Orthopedics
         Endocrinology
         Rheumatology
      image:
      isPartOf:
         name:Osteoporosis International
         issn:
            1433-2965
            0937-941X
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag London Limited
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:P. J. Meunier
            affiliation:
                  name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
                  address:
                     name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. Vignot
            affiliation:
                  name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
                  address:
                     name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
                     type:PostalAddress
                  type:Organization
            type:Person
            name:P. Garnero
            affiliation:
                  name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
                  address:
                     name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. Confavreux
            affiliation:
                  name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
                  address:
                     name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. Paris
            affiliation:
                  name:Centre Lyonnais d’Investigation des Osteoporoses (CLIOS), Lyon, France
                  address:
                     name:Centre Lyonnais d’Investigation des Osteoporoses (CLIOS), Lyon, France, , FR
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Liu-Leage
            affiliation:
                  name:Lilly France (Saint Cloud), Saint Cloud, France;
                  address:
                     name:Lilly France (Saint Cloud), Saint Cloud, France;, , FR
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Sarkar
            affiliation:
                  name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
                  address:
                     name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T. Liu
            affiliation:
                  name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
                  address:
                     name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. Wong
            affiliation:
                  name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
                  address:
                     name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. W. Draper
            affiliation:
                  name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
                  address:
                     name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Osteoporosis International
      issn:
         1433-2965
         0937-941X
      volumeNumber:10
Organization:
      name:Springer-Verlag London Limited
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
      address:
         name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
         type:PostalAddress
      name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
      address:
         name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
         type:PostalAddress
      name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
      address:
         name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
         type:PostalAddress
      name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
      address:
         name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
         type:PostalAddress
      name:Centre Lyonnais d’Investigation des Osteoporoses (CLIOS), Lyon, France
      address:
         name:Centre Lyonnais d’Investigation des Osteoporoses (CLIOS), Lyon, France, , FR
         type:PostalAddress
      name:Lilly France (Saint Cloud), Saint Cloud, France;
      address:
         name:Lilly France (Saint Cloud), Saint Cloud, France;, , FR
         type:PostalAddress
      name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
      address:
         name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
         type:PostalAddress
      name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
      address:
         name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
         type:PostalAddress
      name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
      address:
         name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
         type:PostalAddress
      name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
      address:
         name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:P. J. Meunier
      affiliation:
            name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
            address:
               name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
               type:PostalAddress
            type:Organization
      name:E. Vignot
      affiliation:
            name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
            address:
               name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
               type:PostalAddress
            type:Organization
      name:P. Garnero
      affiliation:
            name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
            address:
               name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
               type:PostalAddress
            type:Organization
      name:E. Confavreux
      affiliation:
            name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
            address:
               name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
               type:PostalAddress
            type:Organization
      name:E. Paris
      affiliation:
            name:Centre Lyonnais d’Investigation des Osteoporoses (CLIOS), Lyon, France
            address:
               name:Centre Lyonnais d’Investigation des Osteoporoses (CLIOS), Lyon, France, , FR
               type:PostalAddress
            type:Organization
      name:S. Liu-Leage
      affiliation:
            name:Lilly France (Saint Cloud), Saint Cloud, France;
            address:
               name:Lilly France (Saint Cloud), Saint Cloud, France;, , FR
               type:PostalAddress
            type:Organization
      name:S. Sarkar
      affiliation:
            name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
            address:
               name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
               type:PostalAddress
            type:Organization
      name:T. Liu
      affiliation:
            name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
            address:
               name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
               type:PostalAddress
            type:Organization
      name:M. Wong
      affiliation:
            name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
            address:
               name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
               type:PostalAddress
            type:Organization
      name:M. W. Draper
      affiliation:
            name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
            address:
               name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
      name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
      name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
      name:Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France, , FR
      name:Centre Lyonnais d’Investigation des Osteoporoses (CLIOS), Lyon, France, , FR
      name:Lilly France (Saint Cloud), Saint Cloud, France;, , FR
      name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
      name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
      name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
      name:Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA, , US
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(43)

• What's the income of https://www.springernature.com/gp/authors?
• Get to know https://link.springernature.com/home/'s earnings
• How much income does https://order.springer.com/public/cart have?
• How much income is https://www.editorialmanager.com/osin/ earning monthly?
• https://www.springernature.com/gp/librarians/licensing/agc/journals's financial summary
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=P.%20J.%20Meunier rake in every month?
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22P.%20J.%20Meunier%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=E.%20Vignot bring in?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22E.%20Vignot%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=P.%20Garnero's revenue stream
• Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22P.%20Garnero%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=E.%20Confavreux rake in every month?
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22E.%20Confavreux%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=E.%20Paris have?
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22E.%20Paris%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S.%20Liu-Leage?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S.%20Liu-Leage%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S.%20Sarkar pull in monthly?
• How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S.%20Sarkar%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
• Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=T.%20Liu
• What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22T.%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Wong bring in each month?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Wong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20W.%20Draper rake in every month?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20W.%20Draper%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
• What's the profit of https://s100.copyright.com/AppDispatchServlet?title=Treatment%20of%20Postmenopausal%20Women%20with%20Osteoporosis%20or%20Low%20Bone%20Density%20with%20Raloxifene&author=P.%20J.%20Meunier%20et%20al&contentID=10.1007%2Fs001980050236©right=International%20Osteoporosis%20Foundation%20and%20National%20Osteoporosis%20Foundation&publication=0937-941X&publicationDate=1999-09&publisherName=SpringerNature&orderBeanReset=true?
• Check the income stats for https://citation-needed.springer.com/v2/references/10.1007/s001980050236?format=refman&flavour=citation
• Monthly income for https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
• https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's total income per month
• How much does https://www.springernature.com/gp/products pull in?
• How much revenue does https://www.springernature.com/gp/librarians bring in?
• How much revenue does https://www.springernature.com/gp/societies generate?
• How much revenue does https://www.springernature.com/gp/partners produce monthly?
• How much cash flow does https://www.springer.com/ have monthly?
• How much does https://www.nature.com/ make?
• What is the earnings of https://www.biomedcentral.com/?
• See how much https://www.palgrave.com/ makes per month
• Discover the revenue of https://www.apress.com/
• How much does https://www.springernature.com/gp/legal/ccpa make?
• Find out how much https://www.springernature.com/gp/info/accessibility earns monthly
• What's the monthly income of https://support.springernature.com/en/support/home?
• https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations's financial summary
• How much money does https://www.springernature.com/ make?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref